CoChat

Excess Mortality Associated With Hypopituitarism in Adults: A Meta-Analysis of Observational Studies

Pappachan, Joseph M., Raskauskiene, Diana, Kutty, V. Raman, Clayton, Richard N. · 2015 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.

Abstract

Context: Several previous observational studies showed an association between hypopituitarism and excess mortality. Reports on reduction of standard mortality ratio (SMR) with GH replacement have been published recently. Objective: This meta-analysis assessed studies reporting SMR to clarify mortality risk in hypopituitary adults and also the potential benefit conferred by GH replacement. Data Sources: A literature search was performed in Medline, Embase, and Cochrane library up to March 31, 2014. Eligibility Criteria: Studies with or without GH replacement reporting SMR with 95% confidence intervals (95% CI) were included. Data Extraction and Analysis: Patient characteristics, SMR data, and treatment outcomes were independently assessed by two authors, and with consensus from third author, studies were selected for analysis. Meta-analysis was performed in all studies together, and those without and with GH replacement separately, using the statistical package metafor in R. Results: Six studies reporting a total of 19 153 hypopituiatary adults with a follow-up duration of more than 99 000 person years were analyzed. Hypopituitarism was associated with an overall excess mortality (weighted SMR, 1.99; 95% CI, 1.21–2.76) in adults. Female hypopituitary adults showed higher SMR compared with males (2.53 vs 1.71). Onset of hypopituitarism at a younger age was associated with higher SMR. GH replacement improved the mortality risk in hypopituitary adults that is comparable to the background population (SMR with GH replacement, 1.15; 95% CI, 1.05–1.24 vs SMR without GH, 2.40; 95% CI, 1.46–3.34). GH replacement conferred lower mortality benefit in hypopituitary women compared with men (SMR, 1.57; 95% CI, 1.38–1.77 vs 0.95; 95% CI, 0.85–1.06). Limitations: There was a potential selection bias of benefit of GH replacement from a post-marketing data necessitating further evidence from long-term randomized controlled trials. Conclusions: Hypopituitarism may increase premature mortality in adults. Mortality benefit from GH replacement in hypopituitarism is less pronounced in women than men.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2014-3787

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 138

Metadata

Authors
Pappachan, J. M., Raskauskiene, D., Kutty, V. R., & Clayton, R. N.
Affiliations
  • Walsall Manor Hospital (GB)
  • Sree Chitra Thirunal Institute for Medical Sciences and Technology (IN)
  • University Hospitals of North Midlands NHS Trust (GB)
Corresponding author
Pappachan, Joseph M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2015-04-01
Volume
100
Issue
4
Pages
1405-1411
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2097556482
Cited by
138
References
34
Citations by year
2026: 6 · 2025: 18 · 2024: 18 · 2023: 19 · 2022: 16 · 2021: 9 · 2020: 13 · 2019: 9 · 2018: 10 · 2017: 10 · 2016: 8 · 2015: 1
FWCI
1.46
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
excess mortality, standardized mortality ratio, growth hormone replacement therapy, premature mortality, sex differences, post-marketing surveillance
MeSH terms
Adult, Female, Humans, Hypopituitarism, Male, Middle Aged, Human Growth Hormone, Hormone Replacement Therapy, Observational Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Excess Mortality Associated With Hypopituitarism in Adults: A Meta-Analysis of Observational Studies. https://app.cochat.ai/papers/10.1210/jc.2014-3787
The paper
Pappachan, J. M., Raskauskiene, D., Kutty, V. R., & Clayton, R. N. (2015). Excess Mortality Associated With Hypopituitarism in Adults: A Meta-Analysis of Observational Studies. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2014-3787

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.